Role of Allogeneic Stem Cell Transplant in the Treatment of Primary Myelofibrosis.-论文-万方医学网

作者： Nur,Soyer ^[1] ; Ferit,Celik ^[2] ; Murat,Tombuloglu ^[1] ; Fahri,Sahin ^[1] ; Guray,Saydam ^[1] ; Filiz,Vural ^[1]

作者单位： Department of Hematology, Ege University Medical Faculty, Izmir, Turkey ^[1] Department of Internal Medicine, Ege University Medical Faculty, Izmir, Turkey ^[2]

主题词急性病(Acute Disease);成年人(Adult);抗原, CD34(Antigens, CD34);慢性病(Chronic Disease);女(雌)性(Female);移植物抗宿主病(Graft vs Host Disease);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);男(雄)性(Male);中年人(Middle Aged);骨髓摘除激动剂(Myeloablative Agonists);原发性骨髓纤维化(Primary Myelofibrosis);复发(Recurrence);回顾性研究(Retrospective Studies);危险因素(Risk Factors);时间因素(Time Factors);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.6002/ect.2016.0007

PMID 27855592

发布时间 2019-06-07

检索历史清除

Role of Allogeneic Stem Cell Transplant in the Treatment of Primary Myelofibrosis.

Experimental and clinical transplantation

相似文献

Experimental and clinical transplantation

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Role of Allogeneic Stem Cell Transplant in the Treatment of Primary Myelofibrosis.

Experimental and clinical transplantation

相似文献

Experimental and clinical transplantation

相关期刊

检索历史清除